Abstract In the United States (US), more than 12 million women reported illicit drug use in
the past month. Drug use has been linked to increased risk for HIV, but little is known about …

Despite pre-exposure prophylaxis's (PrEP) efficacy for HIV prevention, uptake has been low
among women with substance use disorders (SUDs) and attributed to women's lack of …

Little is known about real-world facilitators of and barriers to pre-exposure prophylaxis
(PrEP) uptake among women prescribed PrEP. We sought to characterize the pathway to …

Little information is known about the cisgender women who seek and initiate pre-exposure
prophylaxis (PrEP) for HIV prevention in the United States. Adherence Enhancement Guided …

Abstract Background Pre-exposure prophylaxis (PrEP) for HIV prevention is indicated for
people who inject drugs (PWID), yet most studies do not focus on PWID. This study …

Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective pill that HIV-negative
individuals can take once daily to prevent HIV infection. Although PrEP is a private, user …

Black and Latina cisgender women are disproportionately impacted by HIV in the US.
Although PrEP is effective at preventing HIV infection, uptake in this population remains low …

Background People who use drugs (PWUD) continue to experience a disproportionate HIV
burden due to drug-and sex-related risk behaviors. Pre-exposure prophylaxis (PrEP) is …

Introduction People who inject drugs have a substantial risk for HIV infection, especially
women who inject drugs (WWID). HIV pre-exposure prophylaxis (PrEP), a highly-effective …

Pre-exposure prophylaxis (PrEP) is an effective but understudied tool for preventing HIV
among women who inject drugs (WWID). This article is the first to explore WWID's rationale …